Recombinant Human Insulin-Like Growth Factor 1 (somatomedin C)

• Cat.No.: IGF1-687H
• Product Overview: Recombinant humanIGF1 was expressed in E. coli.

Specification

• Species: Human
• Source: E.coli
• Tag: Non
• Description: Human [Leu24][Alai"] Insulin-like Growth Factor-I (IGF-I) is an analog of human IGF-I witha Leu substitution in place of Tyr at position 24 and an Ala for Tyr atposition 31 of the human IGF-I sequence. Human [Leu24] [Ala31]IGF-I has greatly reduced binding to the Type 1 IGF receptor and to theinsulin receptor compared to IGF [Leu24] IGF-I. and [Leu60]IGF-I. Human [Leu24] [Alai"] IGF-I has normal binding toacid-stripped humanserum binding proteins.
• Purity: Greater than 95% (byHPLC and N-terminal sequence analysis).
• Molecular Weight: 7.507 kDa
• Endotoxin Level: Less than 0.1 EU/ug
• Biological Activity: Type 1 IGF receptorbinding assay-ED50 >750 ng/ml. IGF binding protein assay-ED50 <10ng/ml. Stimulation of protein synthesis in rat L6 myoblasts: ED50 >2000ng/ml.
• State and appearance: Lyophilized whitepowder. Dried from 0.1 M acetic acid and stored under dry nitrogen at aslight vacuum (-25 kPa).
• N-terminal sequenceanalysis: 5 residues Greaterthan 95% single sequence.
• Storage: At least 2 years at2-4°C (lyophilized).
• OfficialSymbol: IGF1

Gene Information

• Gene Name: IGF1 insulin-like growth factor1 (somatomedin C) [ Homo sapiens ]
• Synonyms: IGF1; insulin-likegrowth factor 1 (somatomedin C); insulin-likegrowth factor 1; MGF; IGF-IA; IGF-IB; somatomedin-C; OTTHUMP00000195080;OTTHUMP00000195081; OTTHUMP00000195082; OTTHUMP00000195083;OTTHUMP00000195084; mechano growth factor; insulin-like growth factor I;insulin-like growth factor IA; insulin-like growth factor IB
• Gene ID: 3479
• mRNA Refseq: NM_000618
• Protein Refseq: NP_000609
• MIM: 147440
• UniProt ID: P05019
• Chromosome Location: 12q23
• Pathway: Adipogenesis;Aldosterone-regulated sodium reabsorption; Apoptosis; Diabetes pathways;Dilated cardiomyopathy; Endochondral Ossification; Focal Adhesion; Glioma;Hemostasis; Id Signaling Pathway; Oocyte meiosis; Pathways in cancer;Platelet activation; Prostate cancer; Synthesis
• Function: growthfactor activity; hormone activity; insulin receptor binding; insulin-likegrowth factor receptor binding; integrin binding; protein binding